Breast Imaging Market Grow Emerging Technologies, Key Players Analysis Forecast through 2026
The increasing awareness about breast health is expected to contribute positively to the growth of the market, says Fortune Business Insights in a report, titled “Breast Imaging Market Size, Share and Global Trend By Imaging Modality (Breast MRI Mammography, Breast Tomosynthesis, Galactography, Scinti-mammography), By End User (Hospitals, Ambulatory Surgery Centres, Diagnostic Centres, Cancer Care Centres), Geography Forecast till 2026” The growing cases of breast cancer around the world is predicted to accelerate the growth of the market.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/breast-imaging-market-100218
Some of the Major Companies in the Breast Imaging Market are:
- GENERAL ELECTRIC COMPANY
- Siemens Ltd.
- Koninklijke Philips N.V.
- Hologic Inc.
- FUJIFILM Holdings Corporation
- SonoCiné
- Dilon Technologies, Inc.
- CMR Naviscan
- Thorlabs, Inc.
- Barco
- DUNE
Request a Sample Copy of Breast Imaging Market: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/breast-imaging-market-100218
According to the report, the increasing emphasis on early diagnosis of breast abnormalities is predicted to enable healthy growth of the breast imaging market. As per the American Cancer Society, from 1989 to 2015, the U.S. witnessed 39% reduction in the mortality rate of patients suffering from breast cancer and in 2017, there were an estimated 3.1 million breast cancer survivors in the U.S. These statistics are a result of early diagnosis of breast abnormalities. The rising government initiatives and reimbursement policies is expected to create growth opportunities for the market in the forthcoming years
Rising Awareness About Early Diagnosis to Propel Growth in North America
Geographically, the global breast imaging market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the market owing to increasing awareness about the early diagnosis of breast cancer. The increasing demand for enhanced diagnostic technologies is expected to create opportunities for the market in North America. Asia Pacific and Middle East & Africa is expected to exhibit high potential for the market owing to the increasing prevalence of breast cancer in African countries. In addition, the rising awareness about breast disorders by non-governmental organizations and women & child care departments is likely to bode well for the market in Africa. In addition, a large pool of undiagnosed patient population in the regions is predicted to boost the market growth.